154 related articles for article (PubMed ID: 23769910)
1. Two receptors are involved in the central functions of kynurenic acid under an acute stress in neonatal chicks.
Yoshida J; Shigemura A; Ogino Y; Denbow DM; Furuse M
Neuroscience; 2013 Sep; 248():194-200. PubMed ID: 23769910
[TBL] [Abstract][Full Text] [Related]
2. Central injection of L- and D-aspartate attenuates isolation-induced stress behavior in chicks possibly through different mechanisms.
Erwan E; Chowdhury VS; Nagasawa M; Goda R; Otsuka T; Yasuo S; Furuse M
Eur J Pharmacol; 2014 Aug; 736():138-42. PubMed ID: 24815376
[TBL] [Abstract][Full Text] [Related]
3. Intracerebroventricular injection of L-proline and D-proline induces sedative and hypnotic effects by different mechanisms under an acute stressful condition in chicks.
Hamasu K; Shigemi K; Tsuneyoshi Y; Yamane H; Sato H; Denbow DM; Furuse M
Amino Acids; 2010 Jan; 38(1):57-64. PubMed ID: 19023642
[TBL] [Abstract][Full Text] [Related]
4. The inimitable kynurenic acid: the roles of different ionotropic receptors in the action of kynurenic acid at a spinal level.
Tuboly G; Tar L; Bohar Z; Safrany-Fark A; Petrovszki Z; Kekesi G; Vecsei L; Pardutz A; Horvath G
Brain Res Bull; 2015 Mar; 112():52-60. PubMed ID: 25677204
[TBL] [Abstract][Full Text] [Related]
5. Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo.
Beggiato S; Antonelli T; Tomasini MC; Tanganelli S; Fuxe K; Schwarcz R; Ferraro L
Eur J Neurosci; 2013 May; 37(9):1470-7. PubMed ID: 23442092
[TBL] [Abstract][Full Text] [Related]
6. Intracerebroventricular injection of L-serine analogs and derivatives induces sedative and hypnotic effects under an acute stressful condition in neonatal chicks.
Asechi M; Tomonaga S; Tachibana T; Han L; Hayamizu K; Denbow DM; Furuse M
Behav Brain Res; 2006 Jun; 170(1):71-7. PubMed ID: 16574253
[TBL] [Abstract][Full Text] [Related]
7. Preferential Disruption of Prefrontal GABAergic Function by Nanomolar Concentrations of the α7nACh Negative Modulator Kynurenic Acid.
Flores-Barrera E; Thomases DR; Cass DK; Bhandari A; Schwarcz R; Bruno JP; Tseng KY
J Neurosci; 2017 Aug; 37(33):7921-7929. PubMed ID: 28729445
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels.
Mok MH; Fricker AC; Weil A; Kew JN
Neuropharmacology; 2009 Sep; 57(3):242-9. PubMed ID: 19523966
[TBL] [Abstract][Full Text] [Related]
9. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.
Hilmas C; Pereira EF; Alkondon M; Rassoulpour A; Schwarcz R; Albuquerque EX
J Neurosci; 2001 Oct; 21(19):7463-73. PubMed ID: 11567036
[TBL] [Abstract][Full Text] [Related]
10. Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors.
Lopes C; Pereira EF; Wu HQ; Purushottamachar P; Njar V; Schwarcz R; Albuquerque EX
J Pharmacol Exp Ther; 2007 Jul; 322(1):48-58. PubMed ID: 17446300
[TBL] [Abstract][Full Text] [Related]
11. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
[TBL] [Abstract][Full Text] [Related]
12. On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress.
Lugo-Huitrón R; Blanco-Ayala T; Ugalde-Muñiz P; Carrillo-Mora P; Pedraza-Chaverrí J; Silva-Adaya D; Maldonado PD; Torres I; Pinzón E; Ortiz-Islas E; López T; García E; Pineda B; Torres-Ramos M; Santamaría A; La Cruz VP
Neurotoxicol Teratol; 2011; 33(5):538-47. PubMed ID: 21763768
[TBL] [Abstract][Full Text] [Related]
13. Intracerebroventricular injection of kynurenic acid attenuates corticotrophin-releasing hormone-augmented stress responses in neonatal chicks.
Yoshida J; Tomonaga S; Ogino Y; Nagasawa M; Kurata K; Furuse M
Neuroscience; 2012 Sep; 220():142-8. PubMed ID: 22732505
[TBL] [Abstract][Full Text] [Related]
14. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
[TBL] [Abstract][Full Text] [Related]
15. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
[TBL] [Abstract][Full Text] [Related]
16. Kynurenic acid attenuates NMDA-induced pial arteriolar dilation in newborn pigs.
Bari F; Nagy K; Guidetti P; Schwarcz R; Busija DW; Domoki F
Brain Res; 2006 Jan; 1069(1):39-46. PubMed ID: 16388784
[TBL] [Abstract][Full Text] [Related]
17. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
[TBL] [Abstract][Full Text] [Related]
18. Excitatory amino acid-induced excitation of dopamine-containing neurons in the rat substantia nigra: modulation by kynurenic acid.
Wu HQ; Schwarcz R; Shepard PD
Synapse; 1994 Mar; 16(3):219-30. PubMed ID: 7515199
[TBL] [Abstract][Full Text] [Related]
19. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
[TBL] [Abstract][Full Text] [Related]
20. Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task.
Phenis D; Vunck SA; Valentini V; Arias H; Schwarcz R; Bruno JP
Psychopharmacology (Berl); 2020 Jun; 237(6):1723-1735. PubMed ID: 32162104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
